Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026)

Bausch Health Companies has disclosed Interest & Investment Income across 18 years of filings, most recently posting $11.0 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 15.38% year-over-year to $11.0 million; the TTM figure through Jun 2026 stood at $45.0 million (up 12.5% YoY), while the FY2025 annual figure was $48.0 million, up 45.45% from the prior year.
• Interest & Investment Income came in at $11.0 million for Q2 2026 at Bausch Health Companies, up from $10.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $15.0 million in Q3 2025 to a low of $2.0 million in Q1 2022.
• Average Interest & Investment Income over 5 years is $7.9 million, with a median of $7.5 million recorded in 2023.
• Year-over-year, Interest & Investment Income jumped 500.0% in 2022 and slipped 15.38% in 2026.
• Over 5 years, Interest & Investment Income stood at $6.0 million in 2022, then grew by 16.67% to $7.0 million in 2023, then increased by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then gained by 22.22% to $11.0 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $11.0 million in Q2 2026, $10.0 million in Q1 2026, and $9.0 million in Q4 2025.